Accelmed Mergers and Acquisitions Summary

Private Equity Firm Profile

Accelmed’s most common sectors for investment aremedical products (65%) and information technology (15%) . The Firm’s most common investment types include venture (58%) and growth capital (29%). In total, Accelmed has invested in 7 US states and 2 different countries.

The Firm’s most common exit type is ipo (100%).

Join Mergr to view Accelmed’s full profile and discover more small private equity firm investors just like it.

M&A Summary

  • M&A Total Activity15
    • M&A Buy Activity14
    • M&A Sell Activity1
  • Total Sectors Invested 5
  • Total Countries Invested 2
  • M&A Buy/Sell Connections 3

Accelmed

848 Brickell Ave, #901,
Miami, Florida 33131
United States
(305) 854-6815
www.accelmed.com
info@accelmed.com

Accelmed is a global investment firm focused on providing investments in small and mid-cap private and public companies. The Firm looks to invest between $20 and $50 million in medical device companies and technologies with revenues greater than $30 million. Prospective transaction types include management buyouts and growth financings. Accelmed was formed in 2009 and is based in New York City.


Investment Criteria

Sectors of Interest: Information Technology, Life Science, Medical Products, Software

Target Transaction Types: Buyout (LBO, MBO, MBI), Growth Capital, Venture

Geographic Preferences: East US, Midwest US, South US, West US, Canada, United Kingdom, Western Europe, Eastern Europe, Scandinavia, Middle East

Transaction Criteria Min Max
Target Revenue 30 -
Target EBITDA - -
Investment Size 20 50
Enterprise Value - -
values in millions of USD

M&A Summary

Buy vs Sell

Year ≤ '20 '21 '22 '23 '24 '25 T
Buy (0.8/yr) # 10 4 - - - - 14
Sell (0.2/yr) # - 1 - - - - 1
  15

Most Recent M&A

Company Date Value Type
Click Therapeutics, Inc. 2021-10-22 - Venture
New York, New York · www.clicktherapeutics.com
Veranex 2021-06-16 - Growth Capital
Raleigh, North Carolina · www.veranexsolutions.com
Neuropace, Inc. 2021-04-21 - IPO
Mountain View, California · www.neuropace.com
Momentis Surgical Ltd. 2021-04-12 - Venture
Or Yehuda, Israel · www.momentissurgical.com
Medminder Systems, Inc. 2021-03-22 - Growth Capital
Needham, Massachusetts · www.medminder.com
Neuropace, Inc. 2020-08-31 - Growth Capital
Mountain View, California · www.neuropace.com
Trukera Medical 2020-05-11 - Growth Capital
Southlake, Texas · www.trukera.com
TailorMed Medical Ltd. 2019-06-27 - Venture
New York, New York · www.tailormed.co
EndoGastric Solutions, Inc. 2019-05-28 - Venture
Redmond, Washington · www.endogastricsolutions.com
Keystone Dental, Inc. 2018-06-04 - Secondary Buyout
Burlington, Massachusetts · www.keystonedental.com
View All >>

M&A by Sector

Sector Current # Value All-time # Value
Medical Products 8 (62%) - 9 (64%) -
Information Technology 2 (15%) - 2 (14%) -
Business Services 1 (8%) - 1 (7%) -
Life Science 1 (8%) - 1 (7%) -
Software 1 (8%) - 1 (7%) -
Total 13 - 14 -

Acquisitions By Geo

State/Country Current # Value All-time # Value
United States 10 (77%) - 11 (79%) -
  New York 3 (23%) - 3 (21%) -
  Massachusetts 3 (23%) - 3 (21%) -
  Washington 1 (8%) - 1 (7%) -
  Texas 1 (8%) - 1 (7%) -
  Pennsylvania 1 (8%) - 1 (7%) -
  North Carolina 1 (8%) - 1 (7%) -
  California - - 1 (7%) -
Israel 3 (23%) - 3 (21%) -
Total 13 - 14 -

Acquisitions by Deal Type

Type Current # Value All-time # Value
Venture 8 (62%) - 8 (57%) -
Growth Capital 3 (23%) - 4 (29%) -
Secondary Buyout 1 (8%) - 1 (7%) -
Stake Purchase 1 (8%) - 1 (7%) -
Total 13 - 14 -

Exits by Deal Type

Type Total # Value
IPO 1 (100%) -
Total 1 -

M&A Connections

Deals
Acquired from
Investor(s)
7%
1 (7%)

Investor Summary

Investor Type

Private Equity Firm

Size

Small

Established

2009

Specialist/Generalist

Specialist

Leadership

Uri Geiger

Co-Founder & Managing Partner

Stephen Rubin

General Partner

Guy Ohad

Chief Medical Officer

Susan Alpert

Chief Regulatory Officer

Ilan Ben-Oren

Chief Technology Officer

 Subscribe to unlock this and 193,848
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More
1 Week Free Trial Learn More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB

Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.5K Private Equity Firms
  • 184K M&A Transactions
  • 189K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.5K M&A Advisors
    (Investment Banks and Law Firms)
  • 72K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.

Mergr

Product

Company

Legal